Skip to content

Therapies for dactylitis in psoriatic arthritis. A systematic review

by Helliwell P.S.
Journal of Rheumatology ()


Dactylitis is a hallmark clinical feature of psoriatic arthritis (PsA). Acute dactylitis appears to be a severity marker for PsA and psoriasis. Traditionally, clinicians have used nonsteroidal antiinflammatory rheumatic drugs and local corticosteroid injections to treat dactylitis, although conventional disease modifying antirheumatic drugs also are recommended. In this systematic review, the limited data on treatments for dactylitis in PsA highlight the need for a valid, reliable, and responsive clinical outcome measure. Infliximab is the only drug to demonstrate significant improvement of dactylitis during a clinical study.

Cite this document (BETA)

Readership Statistics

5 Readers on Mendeley
by Discipline
40% Medicine and Dentistry
20% Nursing and Health Professions
20% Business, Management and Accounting
by Academic Status
20% Other
20% Lecturer
20% Librarian

Sign up today - FREE

Mendeley saves you time finding and organizing research. Learn more

  • All your research in one place
  • Add and import papers easily
  • Access it anywhere, anytime

Start using Mendeley in seconds!

Sign up & Download

Already have an account? Sign in